# Antibodies.com

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/antibodies-com

- Industry: Internet
- Headquarters: Cambridge, UK
- Website: www.antibodies.com
- Total disclosed funding: $0.4M
- Latest round: Seed (Feb 25, 2019)
- Investors on record: 1

## About

Antibodies.com Limited is a UK-based company that specializes in the development and distribution of high-quality research products, focusing on antibodies, recombinant proteins, and ELISA kits for various scientific applications.Founded in 2015 in Cambridge, UK, Antibodies.com Limited develops and distributes research products, particularly in the field of immunology. The company raised GBP 335 thousand in Seed funding in February 2019, led by Nidobirds Ventures GmbH, valuing it at GBP 1.81 million post-money. The founders, Sebastian Newlove and Stewart Newlove, have significant experience in the life sciences sector.Antibodies.com specializes in high-quality research products, focusing on primary and secondary antibodies, recombinant proteins, and ELISA kits. Their offerings are utilized in various applications, supporting researchers worldwide, with products cited in over 350 scientific journals.Antibodies.com generates revenue through direct sales of its research products to academic institutions, healthcare facilities, and biotechnology companies. Pricing is based on product complexity and discounts for new labs are available. Key products include the Mouse SIRT2 ELISA Kit and Anti-His Tag Antibody.Antibodies.com plans to use the recent Seed funding of GBP 335 thousand to enhance product development and support new product launches. The company is targeting expansion into European and Asia Pacific markets by 2025, focusing on increasing its portfolio of ELISA kits and recombinant proteins.

## Funding rounds

- Seed, Feb 25, 2019, $0.4M — Nidobirds Ventures

## Investors

- Nidobirds Ventures (https://capitalatlas.ai/funds/nidobirds-ventures) — Seed